[1] 《新型冠状病毒感染住院患者血栓预防和抗凝管理指南》工作组, 中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 等. 新型冠状病毒感染住院患者血栓预防和抗凝管理指南[J]. 中华医学杂志, 2023, 103(12): 863-885.
[2] Task Force for the management of COVID-19 of the European Society of Cardiology, BAIGENT C, WINDECKER S, et al. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis[J]. Cardiovasc Res, 2022, 118(6):1385-1412.
[3] FRANCHINI M, TARGHER G, MONTAGNANA M, et al. Iron and thrombosis[J]. Ann Hematol, 2008,87(3):167-173.
[4] BOUREAU A S, ANNWEILER C, BELMIN J, et al. Practical management of frailty in older patients with heart failure: statement from a panel of multidisciplinary experts on behalf the Heart Failure Working Group of the French Society of Cardiology and on behalf French Society of Geriatrics and Gerontology[J]. ESC Heart Fail, 2022, 9(6):4053-4063.
[5] ANDREOTTI F, GEISLER T, COLLET J P, et al. Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis[J]. Eur Heart J, 2023, 44(4):262-279.
[6] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.冠心病合并心房颤动患者抗栓管理中国专家共识[J]. 中华心血管病杂志,2020,48(7):552-564.
[7] 中国医师协会心血管内科医师分会血栓防治专业委员会,中华医学会心血管病学分会介入心脏病学组,中华心血管病杂志编辑委员会.急性冠状动脉综合征特殊人群抗血小板治疗中国专家建议[J].中华心血管病杂志,2018,46(4):255-266.
[8] TAN J W C, CHEW D P, TSUI K L, 等.2021亚太心脏病学会P2Y12受体拮抗剂应用于亚太特殊人群的共识[J].中华心血管病杂志,2023,51(1):19-31. |
